Global Deep Sea Fish Oil Market to Reach USD 1.87 Billion by 2032, Growing at 3.0% CAGR | Rising Omega-3 Demand & Aquaculture Expansion Drive Growth
Global Deep Sea Fish Oil Market continues to expand steadily, driven by increasing consumer awareness about omega-3 health benefits and the rapid growth of the global aquaculture sector. According to Intel Market Research, the market was valued at US$ 1,525 million in 2024 and is projected to reach US$ 1,871 million by 2032, registering a CAGR of 3.0% from 2025 to 2032. Deep sea fish oil—extracted primarily from species such as anchovies, sardines, and mackerel—is rich in EPA and DHA, essential long-chain omega-3 fatty acids linked to cardiovascular health, cognitive function, and inflammation reduction.

Goodbye everyone, I'll remember you all in therapy

This little ringtail possum visits every night for a drink of water, a few grapes and a slice of orange.

Global Afamelanotide Market (2024–2032): USD 136.27M to USD 258.01M Growth at 9.1% CAGR
Global Afamelanotide Market is expected to grow from USD 136.27 million in 2024 to USD 258.01 million by 2032, registering a strong CAGR of 9.1% during 2025–2032. Market expansion is fueled by rising cases of rare phototoxic disorders such as Erythropoietic Protoporphyria (EPP), increased awareness about orphan diseases, and advancements in melanocortin-based peptide therapies.Afamelanotide, marketed as SCENESSE®, is the first and only FDA- and EMA-approved treatment for EPP. By stimulating melanin production, it offers significant photoprotection and improves sunlight tolerance, making it a breakthrough therapy for patients suffering from severe light sensitivity. Clinical pipelines exploring applications in vitiligo, photodermatoses, and select neurological disorders are further expanding market potential.